Published

Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: EClinicalMedicine
Date: 2023-02-01
Source: PubMed
DOI: 10.1016/j.eclinm.2023.101841
PubMed: 36747965

Authors

von Rotz R Schindowski EM Jungwirth J Schuldt A Rieser NM Zahoranszky K Seifritz E Nowak A Nowak P Jäncke L Preller KH Vollenweider FX

Watch author

Derived topics and classifications

psilocybin Depression Clinical Trial Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications2026-04-01

Related papers

Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.EClinicalMedicine · 2023-02-01 A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10 Psilocybin increases emotional empathy in patients with major depression.Molecular psychiatry · 2025-06-01